Regular Physical Activity Engaging in regular physical activity can greatly improve your gastrointestinal health and help trigger bowel movements
Here's what you should know going in: Commonly reported effects include nausea, vomiting, diarrhea, and constipation, particularly during initial dose escalation Warnings and precautions in the prescribing information for applicable semaglutide and tirzepatide products cover pancreatitis, gallbladder disease, and kidney injury associated with volume depletion If you're on insulin or sulfonylureas, discuss hypoglycemia risk with your prescriber - GLP-1 medications can affect blood sugar control when combined with those drugs These medications slow gastric emptying, which can affect how orally taken medications are absorbed - worth flagging if you take other oral drugs regularly Certain FDA-approved semaglutide and tirzepatide products carry a boxed warning concerning thyroid C-cell tumors observed in rodents
Medicaid coverage for semaglutide Coverage varies by state
Disclaimer: While Semaglutide has shown strong results in clinical trials, individual outcomes can vary
Standard Blood Tests: What They Detect What your clinician orders on a CBC, BMP, CMP, or lipid profile is information about your physiology, not a report of every chemical floating through your veins
